Koga Hiroki, Kai Keita, Aishima Shinichi, Kawaguchi Atsushi, Yamaji Koutaro, Ide Takao, Ueda Junji, Noshiro Hirokazu
Department of Surgery, Saga University Faculty of Medicine, Saga 849-8501, Japan.
Department of Pathology, Saga University Hospital, Saga 849-8501, Japan.
World J Hepatol. 2017 Dec 18;9(35):1286-1295. doi: 10.4254/wjh.v9.i35.1286.
To investigate the prevalence, clinicopathological characteristics and surgical outcomes of occult hepatitis B virus (HBV) infection (OBI) in patients with non-B, non-C (NBNC) hepatocellular carcinoma (HCC).
This study retrospectively examined the cases of 78 NBNC patients with curative resection for HCC for whom DNA could be extracted from formalin-fixed paraffin-embedded tissue. OBI was determined by the HBV-DNA amplification of at least two different sets of primers by TaqMan real-time polymerase chain reaction. Possibly carcinogenetic factors such as alcohol abuse, diabetes mellitus, obesity and non-alcoholic steatohepatitis (NASH) were examined. Surgical outcomes were evaluated according to disease-free survival (DFS), overall survival (OS) and disease-specific survival (DSS).
OBI was found in 27/78 patients (34.6%) with NBNC HCC. The OBI patients were significantly younger than the non-OBI cases at the time of surgery (average age 63.0 68.1, = 0.0334) and the OBI cases overlapped with other etiologies significantly more frequently compared to the non-OBI cases ( = 0.0057). OBI had no impact on the DFS, OS or DSS. Only tumor-related factors affected these surgical outcomes.
Our findings indicate that OBI had no impact on surgical outcomes. The surgical outcomes of NBNC HCC depend on early tumor detection; this reconfirms the importance of a periodic medical examination for individuals who have NBNC HCC risk factors.
探讨非B、非C型(NBNC)肝细胞癌(HCC)患者隐匿性乙型肝炎病毒(HBV)感染(OBI)的患病率、临床病理特征及手术疗效。
本研究回顾性分析了78例接受HCC根治性切除术且可从福尔马林固定石蜡包埋组织中提取DNA的NBNC患者的病例。通过TaqMan实时聚合酶链反应,采用至少两组不同引物进行HBV-DNA扩增来确定OBI。检测可能的致癌因素,如酗酒、糖尿病、肥胖和非酒精性脂肪性肝炎(NASH)。根据无病生存期(DFS)、总生存期(OS)和疾病特异性生存期(DSS)评估手术疗效。
78例NBNC HCC患者中,27例(34.6%)发现存在OBI。手术时,OBI患者明显比非OBI患者年轻(平均年龄63.0对68.1,P = 0.0334),与非OBI患者相比,OBI患者与其他病因重叠的频率明显更高(P = 0.0057)。OBI对DFS、OS或DSS无影响。只有肿瘤相关因素影响这些手术疗效。
我们的研究结果表明,OBI对手术疗效无影响。NBNC HCC的手术疗效取决于早期肿瘤检测;这再次证实了对有NBNC HCC危险因素的个体进行定期体检的重要性。